+65.3%
GSK vs MDY
+56.8%
+8.5%
-28.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | MDY | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.5% | -0.1% | +0.6% | +0.6% |
| 7D | +1.1% | +2.3% | -1.1% | +0.6% |
| 30D | +6.3% | +2.0% | +4.3% | +5.8% |
| 3M | +1.8% | -5.6% | +7.5% | +3.3% |
| 6M | +1.7% | +1.3% | +0.4% | +1.1% |
| YTD | +6.5% | +12.3% | -5.8% | +3.3% |
| 1Y | +9.5% | +15.8% | -6.3% | +5.4% |
| 3Y | +65.3% | +56.5% | +8.8% | +50.0% |
| All | +65.3% | +56.8% | +8.5% | +50.0% |
Cumulative growth
Daily Returns
Daily percentage return beside MDY.
Daily Out/Under-Performance
Portfolio return minus MDY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MDY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded MDY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling